Literature DB >> 10335515

Survey of multiple sclerosis in northern California. Northern California MS Study Group.

D S Goodin1.   

Abstract

A random sample of 493 multiple sclerosis (MS) patients registered with the Northern California Chapter of the National MS Society was surveyed by mail and subsequently interviewed with regard to their MS, life style, diet, medical treatment, family history, and insurance coverage. Of this sample, 168 patients (34%) returned completed questionnaires. The answers on the questionnaire were entered into a database and scores on the extended disability status scale (EDSS), the neurologic rating scale (NRS), the ambulation index (AI), and the mean disability scale (MDS) were determined from the patient's answers to a portion of the questionnaire using a previously validated conversion program. This survey population of 168 patients seemed to represent well both the random sample and the frame population from which it was drawn. Patients commonly experienced symptoms for which there are medical treatments currently available such as bladder symptoms, fatigue, spasticity, pain, and depression. Surprisingly, however, with the exception of spasticity, patients were only infrequently treated for these complaints. In addition, despite the recent approval of the beta-interferons and copolymer I in the treatment of MS, only 74% of the appropriate candidates for such treatment had these options discussed with them and only 45% ever actually received such treatment. Certain clinical features and dietary habits were strongly associated with both EDSS scores and total disability. Not unexpectedly, either a progressive disease course or the presence of neurological dysfunction in any one of a number of functional areas (e.g. bladder, vision, cognitive change, etc.) correlated with higher EDSS scores and greater total disability. Fatigue was also strongly correlated with disability. Indeed, fatigue accounted (in whole or in part) for 65% of the disability experienced by patients; an observation which only underscores the fact that fewer than one third of the patients who experience fatigue have ever been tried on medications. Interestingly, the only factors associated with lower EDSS scores and less total disability were exercise and alcohol consumption. Such associations from a single survey, however, do not establish causation. It is the purpose of this study to establish a baseline level of function within this survey population so that future surveys in the same set of individuals can allow a prospective assessment of how health outcome has influenced different aspects of the patient's medical care, lifestyle, and insurance coverage.

Entities:  

Mesh:

Year:  1999        PMID: 10335515     DOI: 10.1177/135245859900500203

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  12 in total

1.  The underdiagnosis of sleep disorders in patients with multiple sclerosis.

Authors:  Steven D Brass; Chin-Shang Li; Sanford Auerbach
Journal:  J Clin Sleep Med       Date:  2014-09-15       Impact factor: 4.062

2.  Burden of a multiple sclerosis relapse: the patient's perspective.

Authors:  Merrikay Oleen-Burkey; Jane Castelli-Haley; Maureen J Lage; Kenneth P Johnson
Journal:  Patient       Date:  2012       Impact factor: 3.883

Review 3.  The epidemiology of alcohol consumption and multiple sclerosis: a review.

Authors:  Yu-Jie Wang; Rui Li; Jun-Wei Yan; Ya-Nan Wan; Jin-Hui Tao; Bing Chen; Xiao-Lei Huang; Guo-Jun Yang; Jing Wang; Dong-Qing Ye
Journal:  Neurol Sci       Date:  2014-11-12       Impact factor: 3.307

4.  A comparison of self-hypnosis versus progressive muscle relaxation in patients with multiple sclerosis and chronic pain.

Authors:  Mark P Jensen; Joseph Barber; Joan M Romano; Ivan R Molton; Katherine A Raichle; Travis L Osborne; Joyce M Engel; Brenda L Stoelb; George H Kraft; David R Patterson
Journal:  Int J Clin Exp Hypn       Date:  2009-04

5.  Quality indicators for multiple sclerosis.

Authors:  Eric M Cheng; Carolyn J Crandall; Christopher T Bever; Barbara Giesser; Jodie K Haselkorn; Ron D Hays; Paul Shekelle; Barbara G Vickrey
Journal:  Mult Scler       Date:  2010-06-18       Impact factor: 6.312

Review 6.  A benefit-risk assessment of baclofen in severe spinal spasticity.

Authors:  Alessandro Dario; Giustino Tomei
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 7.  Modifiable comorbidities and disability in multiple sclerosis.

Authors:  Shannon Overs; Christina M Hughes; Jodie K Haselkorn; Aaron P Turner
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

8.  The effect of smoking on the symptoms and progression of multiple sclerosis: a review.

Authors:  Afsaneh Shirani; Helen Tremlett
Journal:  J Inflamm Res       Date:  2010-09-01

Review 9.  The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review.

Authors:  Ruth Ann Marrie; Stephen Reingold; Jeffrey Cohen; Olaf Stuve; Maria Trojano; Per Soelberg Sorensen; Gary Cutter; Nadia Reider
Journal:  Mult Scler       Date:  2015-01-12       Impact factor: 6.312

10.  Benefits of repetitive transcranial magnetic stimulation (rTMS) for spastic subjects: clinical, functional, and biomechanical parameters for lower limb and walking in five hemiparetic patients.

Authors:  Luc Terreaux; Raphael Gross; Fabien Leboeuf; Hubert Desal; Olivier Hamel; Jean Paul Nguyen; Chantal Pérot; Kévin Buffenoir
Journal:  ScientificWorldJournal       Date:  2014-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.